March 24, 2020 / 12:18 PM / 5 days ago

BRIEF-Windtree To Pursue Clinical Study Of Lung Injury Treatment In COVID-19 Patients With Its Kl4 Surfactant Therapy

March 24 (Reuters) - Windtree Therapeutics Inc:

* WINDTREE TO PURSUE CLINICAL STUDY OF LUNG INJURY TREATMENT IN COVID-19 PATIENTS WITH ITS KL4 SURFACTANT THERAPY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below